MedPath

Safety Study of the Rapid System for Acute Ischemic Stroke

Phase 1
Completed
Conditions
Acute Ischemic Stroke
Interventions
Device: Rapid System
Registration Number
NCT01404403
Lead Sponsor
Rapid Medical
Brief Summary

This is a safety study of the Rapid System for acute ischemic stroke.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Patients ≥18 to <85 years old
  • Pre stroke modified Rankin Scale (mRS) of ≤2
  • A signed informed consent by patient or a legally acceptable representative
Exclusion Criteria
  • Pre-stroke life expectancy of less than 6 months
  • Current participation in another investigational drug or device study
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Stroke patientsRapid System-
Primary Outcome Measures
NameTimeMethod
Percentage of participants with Adverse Device Effects (ADEs) Percentage of participants with Adverse Device Effects (ADEs)Percentage12 patients
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Karolinska Hospital

🇸🇪

Stockholm, Solna, Sweden

© Copyright 2025. All Rights Reserved by MedPath